title: Concluding remarks and outlook for the use of 5-HT3 receptor antagonists in rheumatology.
authors.affiliation: Friedrich Baur Institute, Munich, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Pongratz
authors.forename: T
authors.initials: T
authors.lastname: Stratz
authors.forename: W
authors.initials: W
authors.lastname: Müller
mesh_terms: D006801:Humans; D012216:Rheumatic Diseases / Q000188:drug therapy*; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000627:therapeutic use*
chemical_list: D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists